Eodyne Systems SL 

Technologies for neurorehabilitation to improve quality of life


Paul Verschure (See Profile)




Sales, licensing phases



Science-based technology with proven clinical effect. Over 20 scientific publications with hundreds of patients.

More than 10 times more affordable than traditional therapy. RGS requires minimum professional intervention.

Market traction, with RGS installed in over 40 health centers in 4 continents.

No other product in the market targets such a wide symptomatology. RGS can treat larger patient populations.

This information is confidential, do not share or copy.

Under evaluation at least till: 25th of September

If you want to have more information or you want to review the project, you have to login or register

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

Aviso de cookies

Log in with your credentials


Forgot your details?

Create Account

Skip to toolbar